SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A Value-Based Insurance Design Program At A Large Company Boosted Medication Adherence For Employees With Chronic Illnesses
6 references·1 citing·27 second hop
A Value-Based Insurance Design Program At A Large Company Boosted Medication Adherence For Employees With Chronic Illnesses (2011)A Value-Based Insurance Design Program At…Evidence That Value-Based Insurance Can Be Effective (2010)Evidence That Value-Based Ins…Value-Based Insurance Design (2007)Value-Based Insurance DesignPrescription drug cost sharing: associations with medication and medical utilization and spending and health. (2007)Prescription drug cost sharin…The effects of prescription drug cost sharing: a review of the evidence. (2005)The effects of prescription d…A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. (2001)A benefit-based copay for pre…Copayments for Ambulatory Care: Penny-Wise and Pound-Foolish (1975)Copayments for Ambulatory Car…The Impact of Reducing Cardiovascular Medication Copayments on Health Spending and Resource Utilization (2012)The Impact of Reducing Cardio…The economics of moral hazard: comment (1982)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)Pharmacy Benefits and the Use of Drugs by the Chronically Ill (2004)Pharmaceutical policies: effects of cap and co-payment on rational drug use (2008)How does copayment for health care services affect demand, health and redistribution? A systematic review of the empirical evidence from 1990 to 2011 (2013)High-Deductible Health Plans Reduce Health Care Cost And Utilization, Including Use Of Needed Preventive Services (2017)Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE (2003)The impact of health care reform on hospital and preventive care: Evidence from Massachusetts (2012)Behavioral Hazard in Health Insurance * (2015)ECONOMIC CRISIS, HEALTH SYSTEMS AND HEALTH IN EUROPE: IMPACT AND IMPLICATIONS FOR POLICY (2015)American Economic Review (2019)Too much ado about two-part models and transformation? (2004)Cost-Effectiveness of Full Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors for Beneficiaries with Diabetes (2005)One size fits all? (2005)Cost-sharing: effects on spending and outcomes. (2010)Health insurance: The tradeoff between risk pooling and moral hazard (1996)Inequality in Quality (2000)Out-of-Pocket Health-Care Expenditures among Older Americans with Cancer (2004)Effects of Increased Patient Cost Sharing on Socioeconomic Disparities in Health Care (2008)Hospitalizations and Deaths Among Adults With Cardiovascular Disease Who Underuse Medications Because of Cost (2010)Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease (2008)Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia (2013)The High Cost of Prescription Drugs in the United States (2016)The Medically Vulnerable: Their Health Risks, Health Status, and Use of Physician Care (1999)Reconsidering the moral hazard-risk avoidance tradeoff (2006)Copayments for ambulatory care in Germany: a natural experiment using a difference-in-difference approach (2009)
this work references cited by second hop

References

  • 2007Prescription drug cost sharing: associations with medication and medical utilization and spending and health.875 cited
  • 2007Value-Based Insurance Design347 cited
  • 2005The effects of prescription drug cost sharing: a review of the evidence.266 cited
  • 2001A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost.184 cited
  • 1975Copayments for Ambulatory Care: Penny-Wise and Pound-Foolish94 cited
  • 2010Evidence That Value-Based Insurance Can Be Effective82 cited

Cited by

  • 2012The Impact of Reducing Cardiovascular Medication Copayments on Health Spending and Resource Utilization70 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work